Bespak
W: https://bespak.com/

Bespak – the specialist inhalation CDMO committed to leading the transition to low carbon pMDIs.

Bespak® is a global contract development and manufacturing organisation (CDMO) solely focused on inhaled drug development. It specialises in inhaled drug products, drug delivery devices and components for the global pharmaceutical market. Headquartered in Holmes Chapel, UK, Bespak provides a specialist, fully integrated service to support customers from early-stage feasibility, analytical and formulation, product development and clinical supply, through to full-scale cGMP batch production.

With a long history in the development and commercial supply of pressurised Metered Dose Inhalers (pMDIs), Bespak supplies a major proportion of the world’s pMDI dosing valves and actuators. It also specialises in the industrialisation and high-volume manufacture of complex Dry Powder Inhaler (DPI) devices, offering industry-leading contract manufacturing services at all scales. Through a joint venture with Medspray, Bespak offers Resyca® Soft Mist Inhalers (SMIs) and nasal soft mist atomisers.

Built on established expertise but ready for the future, Bespak is a long-term innovation partner committed to driving sustainability in the industry. The company has both established capacity and ongoing expansions to enable the manufacture of pMDIs with both low Global Warming Potential (GWP) propellants (HFA-152a and HFO-1234ze), making it well positioned to lead the transition to climate-friendly pMDI’s.